163 related articles for article (PubMed ID: 35419562)
1. A Single Transcript Knockdown-Replacement Strategy Employing 5' UTR Secondary Structures to Precisely Titrate Rescue Protein Translation.
Millette MM; Holland ED; Tenpas TJ; Dent EW
Front Genome Ed; 2022; 4():803375. PubMed ID: 35419562
[TBL] [Abstract][Full Text] [Related]
2. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
[TBL] [Abstract][Full Text] [Related]
3. An RNAi strategy for treatment of amyotrophic lateral sclerosis caused by mutant Cu,Zn superoxide dismutase.
Xia XG; Zhou H; Zhou S; Yu Y; Wu R; Xu Z
J Neurochem; 2005 Jan; 92(2):362-7. PubMed ID: 15663483
[TBL] [Abstract][Full Text] [Related]
4. Downstream Effects of Mutations in
Dash BP; Freischmidt A; Weishaupt JH; Hermann A
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077049
[TBL] [Abstract][Full Text] [Related]
5. FUS and TARDBP but not SOD1 interact in genetic models of amyotrophic lateral sclerosis.
Kabashi E; Bercier V; Lissouba A; Liao M; Brustein E; Rouleau GA; Drapeau P
PLoS Genet; 2011 Aug; 7(8):e1002214. PubMed ID: 21829392
[TBL] [Abstract][Full Text] [Related]
6. In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse model.
Chen YA; Kankel MW; Hana S; Lau SK; Zavodszky MI; McKissick O; Mastrangelo N; Dion J; Wang B; Ferretti D; Koske D; Lehman S; Koszka K; McLaughlin H; Liu M; Marshall E; Fabian AJ; Cullen P; Marsh G; Hamann S; Craft M; Sebalusky J; Arnold HM; Driscoll R; Sheehy A; Luo Y; Manca S; Carlile T; Sun C; Sigrist K; McCampbell A; Henderson CE; Lo SC
Gene Ther; 2023 May; 30(5):443-454. PubMed ID: 36450833
[TBL] [Abstract][Full Text] [Related]
7. Induced pluripotent stem cell-derived motor neurons from amyotrophic lateral sclerosis (ALS) patients carrying different superoxide dismutase 1 mutations recapitulate pathological features of ALS.
Liu WC; Liu N; Wang Y; Huang C; Li YF; Wang H; Li XG; Deng M
Chin Med J (Engl); 2021 Oct; 134(20):2457-2464. PubMed ID: 34669638
[TBL] [Abstract][Full Text] [Related]
8. Genetics of amyotrophic lateral sclerosis: seeking therapeutic targets in the era of gene therapy.
Suzuki N; Nishiyama A; Warita H; Aoki M
J Hum Genet; 2023 Mar; 68(3):131-152. PubMed ID: 35691950
[TBL] [Abstract][Full Text] [Related]
9. Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism.
Ferraiuolo L; Meyer K; Sherwood TW; Vick J; Likhite S; Frakes A; Miranda CJ; Braun L; Heath PR; Pineda R; Beattie CE; Shaw PJ; Askwith CC; McTigue D; Kaspar BK
Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6496-E6505. PubMed ID: 27688759
[TBL] [Abstract][Full Text] [Related]
10. Comparing effects of microgravity and amyotrophic lateral sclerosis in the mouse ventral lumbar spinal cord.
Yoshikawa M; Ishikawa C; Li H; Kudo T; Shiba D; Shirakawa M; Muratani M; Takahashi S; Aizawa S; Shiga T
Mol Cell Neurosci; 2022 Jul; 121():103745. PubMed ID: 35660087
[TBL] [Abstract][Full Text] [Related]
11. Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model.
Turner BJ; Parkinson NJ; Davies KE; Talbot K
Neurobiol Dis; 2009 Jun; 34(3):511-7. PubMed ID: 19332122
[TBL] [Abstract][Full Text] [Related]
12. Neuromuscular effects of G93A-SOD1 expression in zebrafish.
Sakowski SA; Lunn JS; Busta AS; Oh SS; Zamora-Berridi G; Palmer M; Rosenberg AA; Philip SG; Dowling JJ; Feldman EL
Mol Neurodegener; 2012 Aug; 7():44. PubMed ID: 22938571
[TBL] [Abstract][Full Text] [Related]
13. Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease.
Abdul Wahid SF; Law ZK; Ismail NA; Lai NM
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011742. PubMed ID: 31853962
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 Deficiency Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutation.
Han Y; Ripley B; Serada S; Naka T; Fujimoto M
PLoS One; 2016; 11(4):e0153399. PubMed ID: 27070121
[TBL] [Abstract][Full Text] [Related]
15. [Glial pathology in amyotrophic lateral sclerosis].
Yamanaka K
Rinsho Shinkeigaku; 2011 Nov; 51(11):1192-4. PubMed ID: 22277531
[TBL] [Abstract][Full Text] [Related]
16. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
17. [Clinical translation of hepatocyte growth factor for amyotrophic lateral sclerosis].
Warita H; Kato M; Suzuki N; Itoyama Y; Aoki M
Rinsho Shinkeigaku; 2012; 52(11):1214-7. PubMed ID: 23196568
[TBL] [Abstract][Full Text] [Related]
18. Gene Therapy in Amyotrophic Lateral Sclerosis.
Fang T; Je G; Pacut P; Keyhanian K; Gao J; Ghasemi M
Cells; 2022 Jun; 11(13):. PubMed ID: 35805149
[TBL] [Abstract][Full Text] [Related]
19. Adeno Associated Viral Vector Delivered RNAi for Gene Therapy of SOD1 Amyotrophic Lateral Sclerosis.
Stoica L; Sena-Esteves M
Front Mol Neurosci; 2016; 9():56. PubMed ID: 27531973
[TBL] [Abstract][Full Text] [Related]
20. Single-cell transcriptomics identifies master regulators of neurodegeneration in SOD1 ALS iPSC-derived motor neurons.
Namboori SC; Thomas P; Ames R; Hawkins S; Garrett LO; Willis CRG; Rosa A; Stanton LW; Bhinge A
Stem Cell Reports; 2021 Dec; 16(12):3020-3035. PubMed ID: 34767750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
